190 related articles for article (PubMed ID: 11316238)
21. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy.
Rocha-Singh KJ; Ahuja RK; Sung CH; Rutherford J
Catheter Cardiovasc Interv; 2002 Oct; 57(2):135-41. PubMed ID: 12357507
[TBL] [Abstract][Full Text] [Related]
22. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
23. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
24. [Effects of methylprednisolone pulse therapy on progressive IgA nephropathy].
Yoshimura M; Kida H; Saito Y; Takaeda M; Sugioka G
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):761-8. PubMed ID: 1770636
[TBL] [Abstract][Full Text] [Related]
25. Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy.
Uchida HA; Nakamura Y; Kaihara M; Norii H; Hanayama Y; Sugiyama H; Maeshima Y; Yamasaki Y; Makino H
Nephrol Dial Transplant; 2006 Dec; 21(12):3475-80. PubMed ID: 16951422
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of steroid pulse therapy in patients with IgA nephropathy.
Kim TY; Kim SB; Park SK
Clin Nephrol; 2012 Aug; 78(2):100-5. PubMed ID: 22790453
[TBL] [Abstract][Full Text] [Related]
27. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
[TBL] [Abstract][Full Text] [Related]
28. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
[TBL] [Abstract][Full Text] [Related]
29. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
[TBL] [Abstract][Full Text] [Related]
30. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
Rasche FM; Klotz CH; Czock D; Karges W; Muche R; Jehle PM; Mertz A; Keller F
Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
[TBL] [Abstract][Full Text] [Related]
31. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
Ohya M; Otani H; Minami Y; Yamanaka S; Mima T; Negi S; Yukawa S; Shigematsu T
Clin Nephrol; 2013 Jul; 80(1):47-52. PubMed ID: 23557791
[TBL] [Abstract][Full Text] [Related]
32. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.
Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT
Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440
[TBL] [Abstract][Full Text] [Related]
33. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of steroid pulse therapy in combination with mizoribine following tonsillectomy for immunoglobulin A nephropathy in renally impaired patients.
Kaneko T; Shimizu A; Tsuruoka S; Iino Y; Katayama Y
J Nippon Med Sch; 2013; 80(4):279-86. PubMed ID: 23995570
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
Sanaka T; Akizawa T; Koide K; Koshikawa S
Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
Kanno A; Hotta O; Yusa N; Taguma Y
Ren Fail; 2007; 29(1):41-7. PubMed ID: 17365909
[TBL] [Abstract][Full Text] [Related]
37. [Effects of steroid therapy in IgA nephropathy].
Ohashi T; Shimokawahara H; Fukumoto M; Azuma K; Uchida Y; Tokuda Y; Ito H; Yasumoto Y; Yamashita W; Harada R
Fukuoka Igaku Zasshi; 1992 May; 83(5):209-15. PubMed ID: 1612550
[TBL] [Abstract][Full Text] [Related]
38. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
39. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
40. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]